Q5156 Injection, tocilizumab-anoh, 1 milligrams
Also known as: tocilizumab biosimilar, IL-6 inhibitor, interleukin inhibitor
Injection of tocilizumab-anoh (Kezar), a biosimilar to tocilizumab, administered at 1 milligram per dose.
In Plain Language
arthritis injection; inflammation blocker; immune disease treatment
Clinical Context
Used for rheumatoid arthritis, giant cell arteritis, and chimeric antigen receptor T-cell cytokine release syndrome. Inhibits interleukin-6 receptor signaling.
RVU Information
CPT Q5156 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5156?
CPT Q5156 (Injection, tocilizumab-anoh, 1 milligrams) is a Q Codes code. Injection of tocilizumab-anoh (Kezar), a biosimilar to tocilizumab, administered at 1 milligram per dose.
Is Q5156 covered by insurance?
Q5156 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for rheumatoid arthritis, giant cell arteritis, and chimeric antigen receptor T-cell cytokine release syndrome. Inhibits interleukin-6 receptor signaling.
When is CPT Q5156 used?
Used for rheumatoid arthritis, giant cell arteritis, and chimeric antigen receptor T-cell cytokine release syndrome. Inhibits interleukin-6 receptor signaling.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.